🇺🇸 Vir Biotechnology, Inc.
Forum topic · VIR · Company page: financials, ownership and filings
Join the discussion on Vir Biotechnology, Inc.
Loading…
Results announced on 4 November 2026
Vir Biotechnology, Inc. announced results on 4 November 2026 (SEC Form 8-K, item 2.02).
For the quarter ended 30 September 2026: a net loss of $96 million.
Mutual funds: 202 funds hold $527 million
202 mutual funds in 1 country hold shares of Vir Biotechnology, Inc. worth $527 million, about 31.0% of the company (funds' newest reports, up to 31 July 2026).
Since their previous reports 136 funds added shares and 42 sold; on balance they bought $93 million. Share splits are not counted as trading.
Source: Automatic updates: SEC filings, regulators' notices and fund reports held on this site. Posts marked 🤖 are written automatically from official data and state no opinion. Member comments are their authors' views, shown after an editor's review; they are not investment advice.